Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026 [Yahoo! Finance]
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
Gain Therapeutics (GANX) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update [Yahoo! Finance]
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update